{
     "PMID": "18343551",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20080722",
     "LR": "20161122",
     "IS": "0278-5846 (Print) 0278-5846 (Linking)",
     "VI": "32",
     "IP": "4",
     "DP": "2008 May 15",
     "TI": "Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.",
     "PG": "1005-12",
     "LID": "10.1016/j.pnpbp.2008.01.016 [doi]",
     "AB": "Glutamate (Glu) is associated with excitotoxic cell damage. Memantine modulates the glutamate induced excitotoxicity in Alzheimer's disease (AD). No information is available as to the influence of memantine on in vivo brain glutamate levels. Hippocampal Glu levels were measured in cognitively impaired and normal individuals (n=10) before and after 6 months of memantine treatment, using three dimensional high spatial resolution (0.5 cm(3) voxels) proton magnetic resonance spectroscopy at 3 T. These measurements were also repeated in a non-treated cognitively normal group (n=6). Treatment with memantine decreased Glu/Cr (creatine) ratio in the left hippocampal region. Memantine reduced hippocampal glutamate levels, which may be consistent with its anti-excitotoxic property.",
     "FAU": [
          "Glodzik, Lidia",
          "King, Kevin G",
          "Gonen, Oded",
          "Liu, Songtao",
          "De Santi, Susan",
          "de Leon, Mony J"
     ],
     "AU": [
          "Glodzik L",
          "King KG",
          "Gonen O",
          "Liu S",
          "De Santi S",
          "de Leon MJ"
     ],
     "AD": "Center for Brain Health, Department of Psychiatry, New York University New York, NY 10016, USA. Lidia.Glodzik-Sobanska@nyumc.org",
     "LA": [
          "eng"
     ],
     "GR": [
          "R01 NS050520/NS/NINDS NIH HHS/United States",
          "R01 AG022374/AG/NIA NIH HHS/United States",
          "R01 AG012101-13/AG/NIA NIH HHS/United States",
          "M01 RR000096/RR/NCRR NIH HHS/United States",
          "R01 EB001015/EB/NIBIB NIH HHS/United States",
          "M01 RR000096-458307/RR/NCRR NIH HHS/United States",
          "NS050520/NS/NINDS NIH HHS/United States",
          "P30 AG008051/AG/NIA NIH HHS/United States",
          "R01 AG022374-02/AG/NIA NIH HHS/United States",
          "P30 AG08051/AG/NIA NIH HHS/United States",
          "R01 AG012101-14/AG/NIA NIH HHS/United States",
          "AG 22374/AG/NIA NIH HHS/United States",
          "R01 AG012101/AG/NIA NIH HHS/United States",
          "R56 NS050520/NS/NINDS NIH HHS/United States",
          "M01RR00096/RR/NCRR NIH HHS/United States",
          "EB01015/EB/NIBIB NIH HHS/United States",
          "R01 AG012101-15/AG/NIA NIH HHS/United States",
          "R01 EB001015-13A2/EB/NIBIB NIH HHS/United States",
          "R01 AG022374-03/AG/NIA NIH HHS/United States",
          "P30 AG008051-199005/AG/NIA NIH HHS/United States",
          "R01 EB001015-12/EB/NIBIB NIH HHS/United States",
          "R01 NS050520-04/NS/NINDS NIH HHS/United States",
          "P30 AG008051-189005/AG/NIA NIH HHS/United States",
          "AG0305/AG/NIA NIH HHS/United States",
          "R01 AG022374-05/AG/NIA NIH HHS/United States",
          "AG12101/AG/NIA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20080207",
     "PL": "England",
     "TA": "Prog Neuropsychopharmacol Biol Psychiatry",
     "JT": "Progress in neuro-psychopharmacology & biological psychiatry",
     "JID": "8211617",
     "RN": [
          "0 (Excitatory Amino Acid Antagonists)",
          "3KX376GY7L (Glutamic Acid)",
          "W8O17SJF3T (Memantine)"
     ],
     "SB": "IM",
     "MH": [
          "Adult",
          "Aged",
          "Aging/metabolism",
          "Alzheimer Disease/drug therapy/metabolism",
          "Cognition Disorders/metabolism",
          "Excitatory Amino Acid Antagonists/*pharmacology/therapeutic use",
          "Female",
          "Glutamic Acid/*metabolism",
          "Hippocampus/drug effects/*metabolism",
          "Humans",
          "Image Processing, Computer-Assisted",
          "Magnetic Resonance Imaging",
          "Magnetic Resonance Spectroscopy",
          "Male",
          "Memantine/*pharmacology/therapeutic use"
     ],
     "PMC": "PMC2789554",
     "MID": [
          "NIHMS52097"
     ],
     "EDAT": "2008/03/18 09:00",
     "MHDA": "2008/07/23 09:00",
     "CRDT": [
          "2008/03/18 09:00"
     ],
     "PHST": [
          "2007/09/09 00:00 [received]",
          "2008/01/08 00:00 [revised]",
          "2008/01/22 00:00 [accepted]",
          "2008/03/18 09:00 [pubmed]",
          "2008/07/23 09:00 [medline]",
          "2008/03/18 09:00 [entrez]"
     ],
     "AID": [
          "S0278-5846(08)00043-2 [pii]",
          "10.1016/j.pnpbp.2008.01.016 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Prog Neuropsychopharmacol Biol Psychiatry. 2008 May 15;32(4):1005-12. doi: 10.1016/j.pnpbp.2008.01.016. Epub 2008 Feb 7.",
     "term": "hippocampus"
}